11/20/2024 10:56 AM | Biodexa Pharmaceuticals (Subject) Brio Capital Master Fund Ltd. (Filed by)
| Form SC 13G/A | |
11/05/2024 5:09 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
11/05/2024 5:12 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
11/05/2024 5:15 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
11/05/2024 5:06 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
11/05/2024 5:06 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
11/05/2024 5:00 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
|
11/05/2024 5:03 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
11/01/2024 4:18 PM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/16/2024 8:12 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
10/16/2024 8:12 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
10/16/2024 8:12 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
10/16/2024 8:12 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
10/16/2024 8:12 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
10/16/2024 8:12 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
10/16/2024 8:12 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
10/15/2024 4:14 PM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/04/2024 7:30 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/27/2024 3:41 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/27/2024 3:41 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/27/2024 3:41 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/27/2024 3:41 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/27/2024 3:41 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/27/2024 3:41 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/27/2024 3:41 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/26/2024 7:42 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/20/2024 3:36 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/20/2024 3:36 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/20/2024 3:36 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/20/2024 3:36 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/20/2024 3:36 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/20/2024 3:36 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/20/2024 3:36 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/19/2024 3:30 PM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/16/2024 7:40 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/06/2024 6:54 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/06/2024 6:54 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/06/2024 6:54 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/06/2024 6:54 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/06/2024 6:54 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/06/2024 6:54 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment (Ad) This isn't just another investment.
It might be the last retirement stock you'll ever need.
But this window of opportunity is closing fast. Click here for the ticker >>> |
09/06/2024 6:54 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
08/30/2024 3:38 PM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/19/2024 11:15 PM | Biodexa Pharmaceuticals (Filer)
| Form EFFECT | |
08/20/2024 5:00 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
08/12/2024 3:36 PM | Biodexa Pharmaceuticals (Filer)
| Form F-1 Registration statement for securities of certain foreign private issuers | |
08/08/2024 3:24 PM | Biodexa Pharmaceuticals (Subject) Iroquois Capital Management, LLC (Filed by)
| Form SC 13G | |
08/01/2024 2:37 PM | Biodexa Pharmaceuticals (Filer)
| Form D Notice of Exempt Offering of Securities | |
07/23/2024 2:09 PM | Biodexa Pharmaceuticals (Subject) Brio Capital Master Fund Ltd. (Filed by)
| Form SC 13G | |
07/23/2024 7:55 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/22/2024 4:13 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
07/22/2024 4:13 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
07/22/2024 4:13 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
07/22/2024 4:13 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
07/22/2024 4:13 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
07/22/2024 4:13 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
07/22/2024 8:34 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B5 | |
07/19/2024 12:00 PM | Biodexa Pharmaceuticals (Filer)
| Form 6-K/A | |
07/19/2024 8:03 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/16/2024 7:46 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/11/2024 4:27 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
07/11/2024 4:27 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
07/11/2024 4:27 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
07/11/2024 4:27 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
07/11/2024 4:27 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
07/11/2024 4:27 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
07/05/2024 4:24 PM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/02/2024 7:44 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/24/2024 7:46 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/16/2024 11:15 PM | Biodexa Pharmaceuticals (Filer)
| Form EFFECT | |
06/17/2024 5:00 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
06/13/2024 8:48 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/29/2024 8:04 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
05/29/2024 8:04 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
05/29/2024 8:04 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
05/29/2024 8:04 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
05/29/2024 8:04 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
05/28/2024 4:03 PM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/22/2024 9:10 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
05/22/2024 9:14 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
05/22/2024 9:16 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
05/22/2024 9:21 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
05/22/2024 8:23 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/21/2024 9:53 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/15/2024 5:46 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/02/2024 11:15 PM | Biodexa Pharmaceuticals (Filer)
| Form EFFECT | |
05/02/2024 11:15 PM | Biodexa Pharmaceuticals (Filer)
| Form EFFECT | |
05/02/2024 11:15 PM | Biodexa Pharmaceuticals (Filer)
| Form EFFECT | |
05/02/2024 11:15 PM | Biodexa Pharmaceuticals (Filer)
| Form EFFECT | |
04/30/2024 12:11 PM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/29/2024 8:47 PM | Biodexa Pharmaceuticals (Filer)
| Form POS AM | |
Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment (Ad) This isn't just another investment.
It might be the last retirement stock you'll ever need.
But this window of opportunity is closing fast. Click here for the ticker >>> |
04/29/2024 8:49 PM | Biodexa Pharmaceuticals (Filer)
| Form POS AM | |
04/29/2024 8:55 PM | Biodexa Pharmaceuticals (Filer)
| Form POS AM | |
04/26/2024 7:45 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/19/2024 7:19 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/18/2024 7:24 PM | Biodexa Pharmaceuticals (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
03/27/2024 11:15 PM | Biodexa Pharmaceuticals (Filer)
| Form EFFECT | |
03/28/2024 5:00 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
03/18/2024 3:31 PM | Biodexa Pharmaceuticals (Filer)
| Form F-1 Registration statement for securities of certain foreign private issuers | |
02/28/2024 3:14 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |